Oxford-Novartis Collaboration for AI in Medicine

About us

The Novartis-Oxford BDI Collaboration for AI in Medicine is a unique large-scale collaboration between the Big Data Institute (BDI) and the international pharmaceutical company Novartis. It is led by Dr. Habib Ganjgahi and Professor Thomas Nichols on the Oxford side, and by Dr. Dieter Haering and Professor Bernd Kieseier on the Novartis side. The collaboration brings together the University of Oxford's Big Data Institute expertise in statistical machine learning and AI with Novartis’s applied problems in drug discovery and development, as well as its rich, high-quality clinical trial database collected over the past 20 years in MS (NO-MS database). The alliance focuses on improving our understanding of multiple sclerosis disease progression and how to interfere with it. By integrating large-scale multimodal data with advanced analytics, the project aims to inform the discovery and development of future therapies and improve the practical management of MS.